Effects of anti-ulcer agents on ethanol-induced gastric mucosal lesions in D-galactosamine-induced hepatitis rats

Arzneimittel-Forschung/Drug Research

Volumn 52, Issue 8, 2002, Pages 600-604

  Taniguchi, Hiroyuki ^a   Yomota, Eiji ^a   Nogi, Koji ^a   Onoda, Yuichi ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Cimetidine; Ecabet; Gastric mucosal lesions, ethanol induced, rat; Hepatitis, D galactosamineinduced, rat; Rebamipide; Sucralfate; Teprenone

Indexed keywords

12 SULFODEHYDROABIETIC ACID; ALCOHOL; ANTIULCER AGENT; CIMETIDINE; GALACTOSAMINE; REBAMIPIDE; SUCRALFATE; TEPRENONE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEPATITIS; LIVER INJURY; MALE; NONHUMAN; PROTECTION; RAT; STOMACH MUCOSA LESION;

EID: 0036354025     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1299937     Document Type: Article

References (31)

1. Gastric lesions in portal hypertension: Inflammatory gastritis or congestive gastropathy?
2. Upper gastrointestinal bleeding in cirrhosis: Clinical and endoscopic correlations
3. Clinical significance of erosive gastritis in patients with alcoholic liver disease and upper gastrointestinal hemorrhage
4. Reduced gastric mucosal blood flow in patients with portal-hypertensive gastropathy
5. Portal hypertension: Its effects on gastric function and ethanol-induced gastric mucosal damage in rats
6. Experimental hepatitis induced by D-galactosamine
7. The trapping of uridine phosphates by D-galactosamine, D-glucosamine, and 2-deoxy-D-galactose: A study on the mechanism of galactosamine hepatitis
8. D-galactosamine and acute liver cell injury
9. Significance of endotoxaemia in experimental "galactosamine-hepatitis" in the rat
10. D-galactosamine hepatotoxicity is associated with endotoxin sensitivity and mediated by lymphoreticular cells in mice
11. Modulation of hepatotoxicity by macrophages in the liver
12. Systemic and hepatic hemodynamic changes in acute liver injury
13. Hepatosplanchnic haemodynamics and renal blood flow and function in rats with liver failure
14. Protective effect of E3330, a novel quinone derivative, in galactosamine-induced hepatitis in rats
15. Protective activity of silipide on liver damage in rodents
16. Sucralfate protection of the gastric mucosa against ethanol-induced injury: A prostaglandin-mediated process?
17. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats
18. Effects of ecabet sodium (TA-2711), a new antiulcer agent, on gastrointestinal mucosal prostanoid production and morphology in rats
19. Role of prostaglandins in regulation of gastric mucosal blood flow and acid secretion
20. 2 enhances gastric defense mechanisms against acid injury in uremic rats
21. Protection against alcohol-induced gastric mucosal injury by geranylgeranylacetone: Effect of indomethacin
22. Tetraprenylacetone promotes healing process of ethanol-induced gastric damage in the rat
23. 2: Favorable effects on rat liver injury
24. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric secretion and experimental ulcers in rats
25. Optimizing acid suppression for treatment of acid-related diseases
26. Role of oxygen radical and lipid peroxidation in indomethacin-induced gastric mucosal injury
27. Free radicals and antioxidant status following pylorus ligation induced gastric mucosal injury in rats
28. Protective effect of rebamipide against hydrogen peroxide-induced hemorrhagic mucosal lesions in rat stomach
29. In vitro studies indicating antioxidative properties of rebamipide
30. Hypergastrinaemia in cirrhosis of liver
31. 2 in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension